NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Had to rework the 3rd paragraph from my last post, just for the sake of clarity.

Some may recall that in earlier years, payments between NWBO and Cognate were in the form of discounted shares and MFN conditions, which was the genesis of the problems with Nasdaq - those payments in shares continued until shortly before Cognate was sold.

Furthermore, there has never been any transparency over time for the amount Toucan may have received in fees from NWBO and Cognate, and the price and capital gains from the sale of Cognate. But in my opinion, the sums are considerable. Even after that practice stopped, during the final settlement in December 2018, the financial obligations between Cognate and NWBO was paid in shares. And then shares were also paid from Cognate to Toucan when Cognate was sold; again, a good sign to accumulate shares, but it does raise questions about how conflicts of interest shaped the terms of the final settlement between and NWBO and Cognate.